Title: Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for
patients with T4b esophageal squamous cell carcinoma
Version: 5 Date: 19 Apr 2024
Reviewer's report:
Despite clarifying some points, the article lacks more deepenig into the characteristics of the
patients treated, hence my suggestion would be re-submit with a higher number of patients and
with more detailed information of the cases.
Title: Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for
patients with T4b esophageal squamous cell carcinoma
Version: 5 Date: 19 Apr 2024
Reviewer's report:
Despite clarifying some points, the article lacks more deepenig into the characteristics of the
patients treated, hence my suggestion would be re-submit with a higher number of patients and
with more detailed information of the cases.
Please review this paper.
user
Title: Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for
patients with T4b esophageal squamous cell carcinoma
Version: 5 Date: 19 Apr 2024
Reviewer's report:
Despite clarifying some points, the article lacks more deepenig into the characteristics of the
patients treated, hence my suggestion would be re-submit with a higher number of patients and
with more detailed information of the cases.
assistant